PRRC1

PRRC1 is a proline-rich cytosolic protein that localizes to ER exit sites and the trans-Golgi network, where it regulates vesicular trafficking at two distinct stations: it interacts with the inner COPII coat to negatively regulate COPII membrane association during ER-to-Golgi transport (PMID:34433667), and it functions as an accessory factor for AP-4-mediated export from the TGN (PMID:41032520). In glioblastoma cells, PRRC1 depletion impairs proliferation and clonogenic survival and enhances γ-H2AX accumulation under genotoxic stress, indicating an additional role in supporting DNA damage tolerance and stress-adaptive fitness (PMID:41932066).

1. 2021 High

   The first mechanistic role for PRRC1 was established at ER exit sites, resolving how a previously uncharacterized proline-rich protein participates in COPII-dependent anterograde trafficking by acting as a negative regulator of COPII coat membrane association.

   Evidence In vitro vesicle formation assay with quantitative mass spectrometry, co-immunoprecipitation for COPII inner coat interaction, PRRC1 depletion showing increased COPII membrane association, and fluorescence microscopy in mammalian cells

   PMID:34433667

   Open questions at the time

   • Structural basis of PRRC1–COPII inner coat interaction is unknown
   • Whether PRRC1 acts catalytically or as a stoichiometric competitor for COPII binding sites is unresolved
   • Cargo specificity of PRRC1-regulated COPII vesicles has not been defined
2. 2025 High

   PRRC1 was shown to operate at a second trafficking station—the trans-Golgi network—where it serves as an essential cytosolic accessory factor for AP-4-mediated vesicle biogenesis, extending its role beyond ER exit sites.

   Evidence In vitro vesicle formation assay in AP-4ε-deficient HeLa cells reconstituted with wild-type conditions, label-free quantitative mass spectrometry identification, and functional depletion confirming loss of AP-4-mediated TGN export

   PMID:41032520

   Open questions at the time

   • Direct binding interface between PRRC1 and AP-4 coat components has not been mapped
   • Whether PRRC1 performs analogous negative regulatory functions at the TGN as at ERES, or a distinct activating role, is unclear
   • Relationship between PRRC1's COPII-regulatory and AP-4-regulatory functions (shared or independent pools) is unknown
3. 2026 Medium

   Beyond vesicular trafficking, PRRC1 was found to support proliferative and stress-adaptive programs in glioblastoma cells, with its loss enhancing DNA damage signaling burden under genotoxic stress, raising the question of whether its trafficking functions feed into genome maintenance indirectly.

   Evidence shRNA-mediated knockdown in U87 and patient-derived GBM lines; clonogenic, anchorage-independent growth, and spheroid assays; γ-H2AX immunofluorescence under genotoxic stress; transcriptomic pathway enrichment

   PMID:41932066

   Open questions at the time

   • Mechanistic link between PRRC1's trafficking role and DNA damage tolerance is not established—cancer phenotypes rely on bioinformatic enrichment rather than direct biochemical evidence
   • Whether PRRC1 acts on chromatin directly or influences DNA damage response indirectly through trafficking-dependent signaling is unknown
   • Findings have not been replicated outside glioblastoma cell models

• It remains unknown how PRRC1's dual trafficking roles at ERES and the TGN are coordinated, whether its proline-rich domain mediates both COPII and AP-4 interactions through shared or distinct binding interfaces, and whether the cancer-associated phenotypes arise from trafficking dysfunction or a separate nuclear function.
• No structural information exists for PRRC1 or its complexes
• In vivo phenotypes in animal models have not been reported
• Whether PRRC1 directly participates in chromatin or DNA repair processes has not been tested biochemically